Vaginal Candidiasis. Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Control group: Clotrimazole vaginal cream1%,Pars Daroo Company , one applicator per day for 1 week. Intervention 2: Intervention group: White alum powder is made from perfumery and wi
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Being between 18 and 45 years old Willingness to participate in the study Being married Existence of clinical signs indicating candidiasis vaginitis Positive wet smear for candida
Exclusion criteria
Exclusion criteria: Pregnancy Breastfeeding Abnormal uterine bleeding Body mass index equal to or greater than 30 History of known chronic diseases: diabetes, weakened immune system, epilepsy, hypertension, etc. History of recurrent candidiasis vulvovaginitis (4 or more than 4 times a year) Existence of other vaginal infections with candidiasis Taking oral contraceptive pills Taking corticosteroids and antibiotics in the last 2 weeks Taking systemic antifungal drugs in the last 4 weeks Taking a cream, suppository or vaginal douche in the last 48 hours History of allergy to clotrimazole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of vaginal candidiasis (including: pruritus, vaginal soreness, dyspareunia, external dysuria, and abnormal vaginal discharge). Timepoint: Before intervention and 7 days after intervention. Method of measurement: Completing the checklist to assess the symptoms vaginal candidiasis and then comparing the frequency of the Symptoms of vaginal candidiasis within and between two groups of treatment.;Signs of vaginal candiasis (Including; vaginal erythema, excoriations, thick white adherent discharge). Timepoint: Before intervention and 7 days after intervention. Method of measurement: Completing the checklist to assess the Signs of Vaginal Candidiasis following vaginal examination and observation. Then comparing the frequency of the signs of vaginal candidiasis within and between two groups of treatment.;The possible side defects of the medications after treatment. Timepoint: During the intervention and 7 days after the intervention. Method of measurement: Completing the checklist to assess the possible side effects of the medications and then comparing the frequency of the side effects within and between two groups of treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mina Iravani
Ahvaz University of Medical Sciences
Outcome results
None listed